A real-world assessment of PIK3CA testing and alpelisib treatment patterns among metastatic breast cancer patients in a community oncology setting

被引：0
|
作者：
O'Shaughnessy, Joyce
Paulson, Steven
Brisbin, Lorraine
Lindsey, James
Williford, Anna
Lisi, Monica
Parikh, Rohan C.
Simmons, Stacey
Balu, Sanjeev
机构：
来源：
CANCER RESEARCH | 2022年 / 82卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS21-P5-13-16
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-13-16
引用
收藏
页数：3
相关论文
共 50 条
  • [1] PIK3CA testing and treatment patterns among patients with metastatic breast cancer in US community clinical practice
    Kim, Eunice
    Dhillon, Preet Kaur
    Lambert, Peter
    Cheng, Anna
    Basho, Reva K.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] Real-world (rw) clinical outcomes on alpelisib (ALP) in patients (pts) with breast cancer (BC) and PIK3CA mutations (PIK3CAm).
    Rugo, Hope S.
    Raskina, Kira
    Schrock, Alexa Betzig
    Israel, Mason A.
    Sokol, Ethan
    Sivakumar, Smruthy
    Ward, Ashley
    Creeden, James
    Oxnard, Geoffrey R.
    McGregor, Kimberly
    Venstrom, Jeffrey Michael
    Tukachinsky, Hanna
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [3] Real-world analysis of eribulin in metastatic breast cancer (MBC): An assessment of time to treatment failure (TTF) in a community oncology setting
    Dranitsaris, George
    Tripathy, Debu
    Beegle, Nancy L.
    Kalberer, Traci L.
    Cox, John David
    Faria, Claudio
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (26)
  • [4] Impact of PIK3CA mutation (PIK3CA-mt) clonality on alpelisib (ALP) activity based on real-world evidence (RWE) following liquid biopsy testing
    Juric, Dejan
    Weipert, Caroline
    Bucheit, Leslie
    Nagy, Rebecca
    Odegaard, Justin
    Yu, Junhua
    Zhang, Nicole
    Liao, Jiemin
    CANCER RESEARCH, 2022, 82 (04)
  • [5] Real-world Treatment Patterns among Patients with Early-Stage Triple-Negative Breast Cancer (TNBC) in a US Community Oncology Setting
    Haiderali, A.
    Pan, W.
    Danso, M.
    Okoth, L.
    Pasha, S.
    Venkatasetty, D.
    Conkling, P.
    BREAST, 2025, 80
  • [6] Real-world PARPi treatment patterns and outcomes among patients with metastatic breast cancer.
    Dawood, Shaheenah S.
    Brzozowski, Kaylen
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [7] Real-world outpatient cost of care among patients with breast cancer treated in the US community oncology setting
    Su, Zhaohui
    Shi, Junxin
    Espirito, Janet
    Niehoff, Nicole
    Aguilar, Kathleen M.
    Herms, Lisa
    O'Sullivan, Amy
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 385 - 385
  • [8] Effectiveness of Alpelisib plus Fulvestrant Compared with Real-World Standard Treatment Among Patients with HR+, HER2-, PIK3CA-Mutated Breast Cancer
    Turner, Stuart
    Chia, Stephen
    Kanakamedala, Hemanth
    Hsu, Wei-Chun
    Park, Jinhee
    Chandiwana, David
    Ridolfi, Antonia
    Yu, Chu-Ling
    Zarate, Juan Pablo
    Rugo, Hope S.
    ONCOLOGIST, 2021, 26 (07): : E1133 - E1142
  • [9] Real-world clinical outcomes in BRCA-positive metastatic breast cancer patients treated in the community oncology setting
    Houts, Arthur C.
    Olufade, Temitope O.
    Shenolikar, Rahul
    Walker, Mark S.
    CANCER RESEARCH, 2018, 78 (04)
  • [10] Real-world treatment patterns and clinical effectiveness outcomes of eribulin in metastatic breast cancer patients in community oncology centers in the United States
    Mougalian, S. S.
    Kish, J. K.
    Zhang, J.
    Miller, T.
    Liassou, D.
    Laney, J.
    Iyer, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S369 - S369
12345